Update information
September 2013: Correction to show that recommendation 1.5 in NICE's technology appraisal guidance on imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours had been updated, rather than recommendation 1.4.
ISBN: 978-1-4731-6654-7